Fund shareholders of Regeneron Pharmaceuticals, Inc.
ISIN US75886F1075 · United States · LEI 549300RCBFWIRX3HYQ56
- Fund shareholders
- 1,130
- Of which ETFs
- 315 815 other funds
- Value held
- 30.8B $ 4.1B SEK · 102.9M €
1,130 funds hold this company. This table lists the 1,113 that declare it in a regulatory filing. The other 17 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 325 | 229.8K $ | 0.06 % | as of Apr 30, 2026 ↗ |
| Columbia Integrated Large Cap Value Fund Columbia Funds Series Trust II | 317 | 247.8K $ | 0.55 % | as of Feb 28, 2026 ↗ |
| Innovator Nasdaq-100 Managed 10 Buffer ETF Innovator ETFs Trust | 315 | 222.7K $ | 1.17 % | as of Apr 30, 2026 ↗ |
| Health Care Fund Rydex Series Funds | 309 | 238.7K $ | 1.24 % | as of Mar 31, 2026 ↗ |
| SPP Generation 50-tal Storebrand Asset Management AS | 303 | 2.2M SEK | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares MSCI Kokusai ETF iShares Trust | 302 | 213.5K $ | 0.09 % | as of Apr 30, 2026 ↗ |
| Transamerica Balanced II TRANSAMERICA FUNDS | 299 | 211.4K $ | 0.30 % | as of Apr 30, 2026 ↗ |
| First Trust Lunt U.S. Factor Rotation ETF First Trust Exchange-Traded Fund | 298 | 230.2K $ | 0.46 % | as of Mar 31, 2026 ↗ |
| MOA ALL AMERICA FUND MoA Funds Corp | 297 | 229.5K $ | 0.08 % | as of Mar 31, 2026 ↗ |
| Nova Fund Rydex Series Funds | 285 | 220.2K $ | 0.10 % | as of Mar 31, 2026 ↗ |
| Invesco Income Advantage U.S. Fund AIM Counselor Series Trust (Invesco Counselor Series Trust) | 284 | 222K $ | 0.11 % | as of Feb 28, 2026 ↗ |
| Alger Russell Innovation ETF Alger ETF Trust | 283 | 218.7K $ | 2.03 % | as of Mar 31, 2026 ↗ |
| S&P 500 2x Strategy Fund Rydex Dynamic Funds | 273 | 210.9K $ | 0.12 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage Large Cap Growth Fund BlackRock Funds | 272 | 212.6K $ | 0.01 % | as of Feb 27, 2026 ↗ |
| EQ/Invesco Moderate Growth Allocation Portfolio EQ Advisors Trust | 269 | 207.8K $ | 0.05 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 267 | 206.3K $ | 1.02 % | as of Mar 31, 2026 ↗ |
| CYBER HORNET S&P 500 Index Funds | 266 | 205.5K $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Länsförsäkringar Sparmål 2025 Länsförsäkringar Fondförvaltning AB | 256 | 1.9M SEK | 0.02 % | as of Mar 31, 2026 ↗ |
| Victory Science & Technology Fund Victory Portfolios III | 252 | 178.2K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| BARRETT GROWTH FUND Segall Bryant & Hamill Trust | 250 | 193.2K $ | 0.88 % | as of Mar 31, 2026 ↗ |
| Gotham Large Value Fund FundVantage Trust | 249 | 192.4K $ | 0.61 % | as of Mar 31, 2026 ↗ |
| Moderate Allocation Fund Meeder Funds | 247 | 190.8K $ | 0.10 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Moderate Allocation Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 246 | 190.1K $ | 0.09 % | as of Mar 31, 2026 ↗ |
| AQR LSE Fusion Fund AQR Funds | 244 | 188.5K $ | 0.99 % | as of Mar 31, 2026 ↗ |
| NEOS Boosted Nasdaq-100(R) High Income ETF NEOS ETF Trust | 244 | 188.5K $ | 0.42 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Momentum Tilt ETF SPDR SERIES TRUST | 242 | 187K $ | 0.12 % | as of Mar 31, 2026 ↗ |
| Impact Shares Women's Empowerment ETF Tidal Trust III | 239 | 184.7K $ | 0.33 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Global Index Core Handelsbanken Fonder AB | 237 | 1.7M SEK | 0.10 % | as of Mar 31, 2026 ↗ |
| Putnam Multi-Asset Income Fund Putnam Asset Allocation Funds | 233 | 182.1K $ | 0.02 % | as of Feb 28, 2026 ↗ |
| Swedbank Robur Access Edge USA Swedbank Robur Fonder AB | 231 | 1.7M SEK | 0.12 % | as of Mar 31, 2026 ↗ |
| Global X Adaptive U.S. Risk Management ETF GLOBAL X FUNDS | 227 | 177.4K $ | 0.13 % | as of Feb 28, 2026 ↗ |
| S&P 500 Fund Rydex Series Funds | 225 | 173.8K $ | 0.12 % | as of Mar 31, 2026 ↗ |
| BlackRock Managed Volatility V.I. Fund BlackRock Variable Series Funds, Inc. | 212 | 163.8K $ | 0.12 % | as of Mar 31, 2026 ↗ |
| ULTRABULL PROFUND ProFunds | 212 | 149.9K $ | 0.07 % | as of Apr 30, 2026 ↗ |
| Symmetry Panoramic Global Equity Fund Symmetry Panoramic Trust | 204 | 159.5K $ | 0.04 % | as of Feb 28, 2026 ↗ |
| EQ/Invesco Moderate Allocation Portfolio EQ Advisors Trust | 202 | 156.1K $ | 0.04 % | as of Mar 31, 2026 ↗ |
| Gotham Enhanced Return Fund FundVantage Trust | 201 | 155.3K $ | 0.04 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) MSCI ACWI Climate Paris Aligned ETF SPDR INDEX SHARES FUNDS | 201 | 155.3K $ | 0.09 % | as of Mar 31, 2026 ↗ |
| AB Dynamic Asset Allocation Portfolio AB VARIABLE PRODUCTS SERIES FUND, INC. | 188 | 145.3K $ | 0.06 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) MSCI World StrategicFactors(SM) ETF SPDR INDEX SHARES FUNDS | 185 | 142.9K $ | 0.08 % | as of Mar 31, 2026 ↗ |
| Large Company Value Portfolio Wilshire Mutual Funds Inc | 184 | 142.2K $ | 0.08 % | as of Mar 31, 2026 ↗ |
| Pacer S&P 500 Quality FCF Aristocrats ETF Pacer Funds Trust | 183 | 129.4K $ | 0.56 % | as of Apr 30, 2026 ↗ |
| WisdomTree U.S. Adaptive Moving Average Fund WisdomTree Trust | 171 | 132.1K $ | 0.15 % | as of Mar 31, 2026 ↗ |
| E*TRADE No Fee Large Cap Index Fund E Trade Trust | 171 | 120.9K $ | 0.11 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 167 | 129K $ | 0.85 % | as of Mar 31, 2026 ↗ |
| Health Care Fund Rydex Variable Trust | 162 | 125.2K $ | 1.00 % | as of Mar 31, 2026 ↗ |
| Symmetry Panoramic US Equity Fund Symmetry Panoramic Trust | 160 | 125.1K $ | 0.03 % | as of Feb 28, 2026 ↗ |
| JPMorgan U.S. Research Enhanced Large Cap ETF J.P. Morgan Exchange-Traded Fund Trust | 156 | 120.5K $ | 0.39 % | as of Mar 31, 2026 ↗ |
| MML Managed Volatility Fund MML SERIES INVESTMENT FUND | 155 | 119.8K $ | 0.14 % | as of Mar 31, 2026 ↗ |
| SA T. Rowe Price VCP Balanced Portfolio SUNAMERICA SERIES TRUST | 155 | 109.6K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| HEALTH CARE ULTRASECTOR PROFUND ProFunds | 153 | 108.2K $ | 1.08 % | as of Apr 30, 2026 ↗ |
| Destinations Shelter Fund Brinker Capital Destinations Trust | 152 | 118.8K $ | 0.13 % | as of Feb 28, 2026 ↗ |
| GodFond Sverige & Världen Storebrand Asset Management AS | 150 | 1.1M SEK | 0.05 % | as of Mar 31, 2026 ↗ |
| The ESG Growth Portfolio HC Capital Trust | 145 | 112K $ | 0.10 % | as of Mar 31, 2026 ↗ |
| ProShares S&P 500 Ex-Financials ETF ProShares Trust | 143 | 111.8K $ | 0.16 % | as of Feb 28, 2026 ↗ |
| Conservative Allocation Fund Meeder Funds | 143 | 110.5K $ | 0.07 % | as of Mar 31, 2026 ↗ |
| SPHERE 500 CLIMATE FUND Exchange Place Advisors Trust | 140 | 108.2K $ | 0.18 % | as of Mar 31, 2026 ↗ |
| Franklin Allocation VIP Fund Franklin Templeton Variable Insurance Products Trust | 138 | 106.6K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| JPMorgan Fundamental Data Science Large Core ETF J.P. Morgan Exchange-Traded Fund Trust | 135 | 104.3K $ | 0.74 % | as of Mar 31, 2026 ↗ |
| Morningstar Global Opportunistic Equity Fund Morningstar Funds Trust | 135 | 95.5K $ | 0.02 % | as of Apr 30, 2026 ↗ |
| ProShares S&P 500 Ex-Energy ETF ProShares Trust | 134 | 104.7K $ | 0.14 % | as of Feb 28, 2026 ↗ |
| Intech S&P Large Cap Diversified Alpha ETF Tidal Trust III | 134 | 94.7K $ | 0.07 % | as of Apr 30, 2026 ↗ |
| Nordea Stratega 15 Nordea Funds Ab | 133 | 968.9K SEK | 0.01 % | as of Mar 31, 2026 ↗ |
| S&P 500 2x Strategy Fund Rydex Variable Trust | 133 | 102.8K $ | 0.12 % | as of Mar 31, 2026 ↗ |
| AQR MS Fusion Fund AQR Funds | 132 | 102K $ | 0.48 % | as of Mar 31, 2026 ↗ |
| STF Tactical Growth ETF Listed Funds Trust | 130 | 100.4K $ | 0.34 % | as of Mar 31, 2026 ↗ |
| Cicero-Optimum US Sector Fund Cicero Fonder AB | 128 | 936.3K SEK | 0.30 % | as of Mar 31, 2026 ↗ |
| ELFUN DIVERSIFIED FUND ELFUN DIVERSIFIED FUND | 127 | 98.1K $ | 0.05 % | as of Mar 31, 2026 ↗ |
| Multi-Asset Strategy Fund RUSSELL INVESTMENT CO | 126 | 89.1K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 125 | 88.4K $ | 0.10 % | as of Apr 30, 2026 ↗ |
| iShares S&P 500 ex S&P 100 ETF iShares Trust | 123 | 95K $ | 0.50 % | as of Mar 31, 2026 ↗ |
| BlackRock Global Allocation Portfolio BlackRock Series Fund, Inc. | 120 | 92.7K $ | 0.06 % | as of Mar 31, 2026 ↗ |
| Gabelli SRI Fund, Inc. Gabelli SRI Fund, Inc. | 117 | 90.4K $ | 0.43 % | as of Mar 31, 2026 ↗ |
| Horizon Equity Premium Income Fund Horizon Funds | 116 | 90.7K $ | 0.06 % | as of Feb 28, 2026 ↗ |
| Federated Hermes Managed Volatility Fund II Federated Hermes Insurance Series | 109 | 84.2K $ | 0.05 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra S&P 500 Equal Weight ProShares Trust | 106 | 82.9K $ | 0.15 % | as of Feb 28, 2026 ↗ |
| SA T. Rowe Price Allocation Moderately Aggressive Portfolio SUNAMERICA SERIES TRUST | 101 | 71.4K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| Global X S&P 500 Covered Call & Growth ETF GLOBAL X FUNDS | 101 | 71.4K $ | 0.11 % | as of Apr 30, 2026 ↗ |
| Fidelity Healthy Future Fund Fidelity Summer Street Trust | 98 | 69.3K $ | 0.47 % | as of Apr 30, 2026 ↗ |
| SEB Global Exposure SEB Funds AB | 97 | 714K SEK | 0.11 % | as of Mar 31, 2026 ↗ |
| Sustainable Equity Fund RUSSELL INVESTMENT CO | 95 | 67.2K $ | 0.03 % | as of Apr 30, 2026 ↗ |
| Xtrackers S&P 500 Diversified Sector Weight ETF DBX ETF Trust | 90 | 70.4K $ | 1.05 % | as of Feb 28, 2026 ↗ |
| JNL/T. Rowe Price Balanced Fund JNL Series Trust | 86 | 66.4K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| LoCorr Strategic Allocation Fund LoCorr Investment Trust | 86 | 66.4K $ | 0.07 % | as of Mar 31, 2026 ↗ |
| Global X NASDAQ 100 Risk Managed Income ETF GLOBAL X FUNDS | 85 | 60.1K $ | 0.37 % | as of Apr 30, 2026 ↗ |
| DoubleLine Fortune 500 Equal Weight ETF DoubleLine ETF Trust | 83 | 64.1K $ | 0.23 % | as of Mar 31, 2026 ↗ |
| Pacer Metaurus Nasdaq 100 Dividend Multiplier 600 ETF Pacer Funds Trust | 83 | 58.7K $ | 0.33 % | as of Apr 30, 2026 ↗ |
| Global Allocation Fund Meeder Funds | 81 | 62.6K $ | 0.16 % | as of Mar 31, 2026 ↗ |
| Global X S&P 500 Risk Managed Income ETF GLOBAL X FUNDS | 81 | 57.3K $ | 0.12 % | as of Apr 30, 2026 ↗ |
| Persimmon Long/Short Fund NORTHERN LIGHTS FUND TRUST III | 80 | 61.8K $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Invesco S&P 500 Downside Hedged ETF Invesco Actively Managed Exchange-Traded Fund Trust | 78 | 55.2K $ | 0.08 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) Russell 1000 Momentum Focus ETF SPDR SERIES TRUST | 71 | 54.9K $ | 0.22 % | as of Mar 31, 2026 ↗ |
| Hartford Schroders Diversified Opportunities Fund HARTFORD MUTUAL FUNDS II, INC | 71 | 50.2K $ | 0.03 % | as of Apr 30, 2026 ↗ |
| Allspring VT Index Asset Allocation Fund Allspring VARIABLE TRUST | 69 | 53.3K $ | 0.08 % | as of Mar 31, 2026 ↗ |
| Disciplined U.S. Value Equity Portfolio GLENMEDE FUND INC | 68 | 48.1K $ | 1.86 % | as of Apr 30, 2026 ↗ |
| First Trust Bloomberg R&D Leaders ETF First Trust Exchange-Traded Fund VI | 67 | 51.8K $ | 1.26 % | as of Mar 31, 2026 ↗ |
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 66 | 51.6K $ | 0.58 % | as of Feb 28, 2026 ↗ |
| PROFUND VP LARGE CAP VALUE ProFunds | 64 | 49.4K $ | 0.30 % | as of Mar 31, 2026 ↗ |
| BULL PROFUND ProFunds | 64 | 45.3K $ | 0.09 % | as of Apr 30, 2026 ↗ |
| Schroders Global Multi-Asset Portfolio Brighthouse Funds Trust I | 63 | 48.7K $ | 0.01 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Direxion Daily Biotech Top 5 Bull 2X ETF Direxion Shares ETF Trust | 8.55 % | as of Apr 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 7.51 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 7.21 % | as of Mar 31, 2026 ↗ |
| Amplify Weight Loss Drug & Treatment ETF Amplify ETF Trust | 6.77 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 6.03 % | as of Feb 28, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 5.46 % | as of Mar 31, 2026 ↗ |
| Longleaf Partners Global Fund Longleaf Partners Funds Trust | 4.83 % | as of Mar 31, 2026 ↗ |
| Longleaf Partners Fund Longleaf Partners Funds Trust | 4.82 % | as of Mar 31, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 4.77 % | as of Apr 30, 2026 ↗ |
| LIVE OAK HEALTH SCIENCES FUND Oak Associates Funds | 4.66 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1,017 | +69 | 40,397,822 | +6.2 % |
| 2026Q1 | 948 | +29 | 38,042,108 | +7.4 % |
| 2025Q4 | 919 | +31 | 35,427,572 | -7.9 % |
| 2025Q3 | 888 | -76 | 38,464,142 | -8.2 % |
| 2025Q2 | 964 | +29 | 41,897,672 | -1.9 % |
| 2025Q1 | 935 | -91 | 42,717,919 | -8.6 % |
| 2024Q4 | 1,026 | -2 | 46,741,888 | -1.0 % |
| 2024Q3 | 1,028 | +4 | 47,228,499 | +0.0 % |
| 2024Q2 | 1,024 | +25 | 47,204,916 | +4.4 % |
| 2024Q1 | 999 | +5 | 45,210,158 | -5.5 % |
| 2023Q4 | 994 | 47,828,710 |
Institutional managers
1,377 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 8,947,735 | 6.9B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,664,478 | 3.6B $ | as of Mar 31, 2026 |
| Dodge & Cox | 4,458,238 | 3.4B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 4,311,806 | 3.2B $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 2,722,071 | 2.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,607,732 | 2B $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,177,527 | 1.7M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 2,065,064 | 1.6B $ | as of Mar 31, 2026 |
| LOOMIS SAYLES & CO L P | 1,912,310 | 1.5B $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,837,459 | 1.4B $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,724,478 | 1.3B $ | as of Mar 31, 2026 |
| FMR LLC | 1,518,192 | 1.2B $ | as of Mar 31, 2026 |
| Capital World Investors | 1,419,000 | 1.1B $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,319,329 | 1B $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,300,558 | 1B $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 1,231,008 | 946M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,189,584 | 919.1M $ | as of Mar 31, 2026 |
| Amundi | 1,009,798 | 780.2M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 941,941 | 727.8M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 812,236 | 627.6M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 804,508 | 621.6M $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 765,411 | 591.4M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 732,054 | 565.6M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 723,621 | 559.1M $ | as of Mar 31, 2026 |
| DEUTSCHE BANK AG\ | 625,388 | 483.2M $ | as of Mar 31, 2026 |
Declared shareholders of Regeneron Pharmaceuticals, Inc.
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 7.37 % | 7,660,810 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Regeneron Pharmaceuticals, Inc.
130 funds declare 156 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Regeneron Pharmaceuticals, Inc.". https://titelia.com/en/stocks/regeneron-pharmaceuticals-inc-US75886F1075